...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment
【24h】

Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment

机译:诊断出高级Gliomas的年轻成人:护理,结果和就业的影响

获取原文
获取原文并翻译 | 示例
           

摘要

There is limited information on the patterns of care and outcomes of high grade gliomas (HGGs) in young adults, in particular, the impact it has on a person's employment. We retrospectively identified young adult patients (age <= 40 years old) with newly diagnosed high grade gliomas treated between January 2013 and June 2018 across four major neuro-oncology centres in Australia. Patient demographics, tumour characteristics and treatment parameters were collected and outcomes determined. A total of 113 patients were identified with a median follow up of 27.0 months (range 1.0-70.2 months). The median age was 31 years, majority were male (65%) and employed (71.6%). IDH mutations were detected in 66 (62%) cases. The median progression-free survival (PFS) was 38.0 months (95% CI 23.3-52.7 months) and median overall survival (OS) was not reached. Patients with IDH wild type anaplastic astrocytoma and glioblastoma had a significantly shorter median PFS (19.3 months vs. NR, p = 0.001) and median OS (43.5 months vs NR, p = 0.007) than those with IDH mutated grade III anaplastic astrocytoma and oligodendroglioma. There was no significant difference in median OS or PFS between patients who underwent gross or subtotal tumour resection. Significantly, after diagnosis only 36 (32%) patients reported being employed.
机译:有关年轻成年人的高级胶质瘤(HGGS)的护理和结果的信息有限的信息,特别是对一个人就业的影响。我们回顾性地确定了年轻的成年患者(年龄<= 40岁),在2013年1月至2018年1月至2018年在澳大利亚的四个主要神经肿瘤中心治疗了新诊断的高级胶质瘤。收集患者人口统计学,肿瘤特征和治疗参数并确定结果。共有113名患者被鉴定为27.0个月(1.0-70.2个月)。中位年龄为31年,大多数是男性(65%),雇用(71.6%)。在66例(62%)病例中检测IDH突变。中位进展的生存期(PFS)是38.0个月(95%CI 23.3-52.7月),并未达到中位数总生存(OS)。含有IDH野生型的患者的内突性星形细胞瘤和胶质母细胞瘤的中位数(19.3个月与NR,P = 0.001)和中位OS(43.5个月,P = 0.007)的中位数(19.3个月,P = 0.007)的中位数PFS(19.3个月,P = 0.007)比含有IDH突变的III级内骨胶星形细胞瘤和少突胚发肌瘤的。在接受毛细管或小肿瘤切除术后的患者之间中位OS或PFS没有显着差异。显着,在诊断后,只有36名(32%)患者被雇用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号